BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27319232)

  • 1. [Clinical implications of polycystic ovary syndrome].
    Dravecká I
    Vnitr Lek; 2016; 62(5):392-7. PubMed ID: 27319232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.
    Mahmoud SA; Zhang L; Jia C; Zang H
    J Reprod Med; 2016; 61(5-6):302-5. PubMed ID: 27424378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and metabolic syndrome.
    Ali AT
    Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midlife women's health consequences associated with polycystic ovary syndrome.
    Ali AT; Guidozzi F
    Climacteric; 2020 Apr; 23(2):116-122. PubMed ID: 31657237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
    Sirmans SM; Parish RC; Blake S; Wang X
    J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic features of polycystic ovary syndrome in adolescents (review).
    Beltadze K; Barbakadze L
    Georgian Med News; 2015 Jan; (238):32-4. PubMed ID: 25693210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregnancy complications among women with polycystic ovary syndrome in China: a Meta-analysis].
    Wang T; Fu H; Chen L; Xu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1300-1310. PubMed ID: 29187658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
    Huang G; Coviello A
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):512-9. PubMed ID: 23108199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric disorders related to polycystic ovary syndrome.
    Krępuła K; Bidzińska-Speichert B; Lenarcik A; Tworowska-Bardzińska U
    Endokrynol Pol; 2012; 63(6):488-91. PubMed ID: 23339008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.
    Panidis D; Tziomalos K; Chatzis P; Papadakis E; Delkos D; Tsourdi EA; Kandaraki EA; Katsikis I
    Eur J Endocrinol; 2013 Feb; 168(2):145-52. PubMed ID: 23109645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].
    Benítez R; Sir-Petermann T; Palomino A; Angel B; Maliqueo M; Pérez F; Calvillán M
    Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term complications of polycystic ovary syndrome (PCOS).
    Peigné M; Dewailly D
    Ann Endocrinol (Paris); 2014 Sep; 75(4):194-9. PubMed ID: 25156132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.